GPX Embolic clinical procedures for tumors and other oncology uses.
GPX® Early Clinical Results
Clinical cases with the GPX Embolic Device from a multi-center clinical trial
Tumor Devascularization
‡
Right renal tumor successfully embolized with GPX resulting in complete occlusion of the target vessels and resolution of chronic hematuria
Baseline angiogram
Angiogram post-GPX delivery through microcatheter
DSA post-GPX delivery
Portal Vein Embolization
‡
Portal vein segment successfully embolized with GPX resulting in a complete cast of a venous system terminal vessel bed and effective occlusion throughout follow-up
Baseline angiogram
Angiogram post-GPX delivery through microcatheter
DSA post-GPX delivery
Interventional Oncology Use
‡
Renal angiomyolipoma embolization completed using interventional oncology techniques resulting in complete occlusion of the target vessels
Baseline angiogram
DSA post-GPX delivery
‡ Early clinical case studies. Data on file. Fluidx Medical Technology, Inc.
The GPX Embolic Device is under development and does not have marketing clearance or approval in any market at this time. For investigational use (in New Zealand) only.